Hi all, I've just received an alert to this stock. It's $2.5. They just had some very positive results from a brain cancer trial 'Berubicin is one of the first anthracyclines that appear to cross the blood-brain barrier and actually kill brain tumor cells in cancer patients.'. Check out the full report. I'm new to trading small caps and have been following Ross Cameron. This seems like a good contender for one of these crazy biotech breakouts?